CCF Webinar: Investigational treatment for KRAS-Mutated Cholangiocarcinoma – An Unmet Need
There are currently no approved therapies for patients with KRAS-mutated cholangiocarcinoma. In this webinar, you will learn about an ongoing Phase 1b/2a study that is aimed to evaluate the combination […]